These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 20947920)
1. How does extracerebral trauma affect the clinical value of S100B measurements? Ohrt-Nissen S; Friis-Hansen L; Dahl B; Stensballe J; Romner B; Rasmussen LS Emerg Med J; 2011 Nov; 28(11):941-4. PubMed ID: 20947920 [TBL] [Abstract][Full Text] [Related]
2. Relationship of serum S100B levels and intracranial injury in children with closed head trauma. Bechtel K; Frasure S; Marshall C; Dziura J; Simpson C Pediatrics; 2009 Oct; 124(4):e697-704. PubMed ID: 19786430 [TBL] [Abstract][Full Text] [Related]
3. High serum S100B levels for trauma patients without head injuries. Anderson RE; Hansson LO; Nilsson O; Dijlai-Merzoug R; Settergren G Neurosurgery; 2001 Jun; 48(6):1255-8; discussion 1258-60. PubMed ID: 11383727 [TBL] [Abstract][Full Text] [Related]
4. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. Savola O; Pyhtinen J; Leino TK; Siitonen S; Niemelä O; Hillbom M J Trauma; 2004 Jun; 56(6):1229-34; discussion 1234. PubMed ID: 15211130 [TBL] [Abstract][Full Text] [Related]
5. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h. Gonzćlez-Mao MC; Repáraz-Andrade A; Del Campo-Pérez V; Alvarez-García E; Vara-Perez C; Andrade-Olivié MA Clin Lab; 2011; 57(7-8):587-97. PubMed ID: 21888023 [TBL] [Abstract][Full Text] [Related]
6. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Rainey T; Lesko M; Sacho R; Lecky F; Childs C Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161 [TBL] [Abstract][Full Text] [Related]
7. Admission S100B fails as neuro-marker but is a good predictor for intrahospital mortality in major trauma patients. Essl D; Schöchl H; Oberladstätter D; Lockie C; Islam M; Slezak C; Voelckel WG Injury; 2024 Jan; 55(1):111187. PubMed ID: 37980176 [TBL] [Abstract][Full Text] [Related]
8. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males. da Rocha AB; Schneider RF; de Freitas GR; André C; Grivicich I; Zanoni C; Fossá A; Gehrke JT; Pereira Jotz G; Kaufmann M; Simon D; Regner A Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136 [TBL] [Abstract][Full Text] [Related]
9. Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults. Rodríguez-Rodríguez A; Egea-Guerrero JJ; León-Justel A; Gordillo-Escobar E; Revuelto-Rey J; Vilches-Arenas A; Carrillo-Vico A; Domínguez-Roldán JM; Murillo-Cabezas F; Guerrero JM Clin Chim Acta; 2012 Dec; 414():228-33. PubMed ID: 23031665 [TBL] [Abstract][Full Text] [Related]
10. Serum S100B protein in early management of patients after mild traumatic brain injury. Morochovic R; Rácz O; Kitka M; Pingorová S; Cibur P; Tomková D; Lenártová R Eur J Neurol; 2009 Oct; 16(10):1112-7. PubMed ID: 19469828 [TBL] [Abstract][Full Text] [Related]
11. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. Baker AJ; Rhind SG; Morrison LJ; Black S; Crnko NT; Shek PN; Rizoli SB J Neurotrauma; 2009 Aug; 26(8):1227-40. PubMed ID: 19637968 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. Geyer C; Ulrich A; Gräfe G; Stach B; Till H J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965 [TBL] [Abstract][Full Text] [Related]
14. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot study. Petzold A; Green AJ; Keir G; Fairley S; Kitchen N; Smith M; Thompson EJ Crit Care Med; 2002 Dec; 30(12):2705-10. PubMed ID: 12483062 [TBL] [Abstract][Full Text] [Related]
15. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666 [TBL] [Abstract][Full Text] [Related]
17. Reliability of S100B in predicting severity of central nervous system injury. Bloomfield SM; McKinney J; Smith L; Brisman J Neurocrit Care; 2007; 6(2):121-38. PubMed ID: 17522796 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article. Wolf H; Frantal S; Pajenda GS; Salameh O; Widhalm H; Hajdu S; Sarahrudi K J Neurosurg; 2013 Jun; 118(6):1298-303. PubMed ID: 23451906 [TBL] [Abstract][Full Text] [Related]
19. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648 [TBL] [Abstract][Full Text] [Related]
20. Comparison between capillary, venous and arterial levels of protein S100B in patients with severe brain pathology. Astrand R; Romner B; Reinstrup P; Friis-Hansen L; Undén J Clin Chem Lab Med; 2012 Jan; 50(6):1055-61. PubMed ID: 22706246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]